COSTIN BERCEANU, ELENA LOREDANA CIUREA, MONICA MIHAELA CIRSTOIU, SABINA BERCEANU, ANCA MARIA OFITERU, CLAUDIA MEHEDINTU, SORIN IOAN BERBECE, RAZVAN CIORTEA, ALEX EMILIAN STEPAN, TUDOR ADRIAN BALSEANU MATERNAL-FETAL MANAGEMENT IN TROMBOPHILIA RELATED AND PLACENTA-MEDIATED PREGNANCY COMPLICATIONS Str., 200349, Craiova, Romania
It is widely accepted that thrombophilia in pregnancy greatly increases the risk of venous thromboembolism. Pregnancy complications arise, at least partly, from placental insufficiency. Any change in the functioning of the gestational transient biological system, such as inherited or acquired thrombophilia, might lead to placental insufficiency. In this research we included 64 pregnant women with trombophilia and 70 cases non-trombophilic pregnant women, with or without PMPC, over a two-year period. The purpose of this multicenter case-control study is to analyze the maternal-fetal management options in obstetric thrombophilia, the impact of this pathology on the placental structure and possible correlations with placenta-mediated pregnancy complications. Maternal-fetal management in obstetric thrombophilia means preconceptional or early diagnosis, prevention of pregnancy morbidity, specific therapy as quickly as possible and fetal systematic surveilance to identify the possible occurrence of placenta-mediated pregnancy complications.